Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Enloe J David Jr, Chairman & CEO. Director active across 2 companies, notably Recro Pharma, Inc.. In total, 21 disclosures have been logged. Breakdown: 14 buys · 0 sell. Total volume traded: €60k. History available since 12 November 2021. The latest transaction was disclosed on 8 April 2024 (U). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Enloe J David Jr
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1,725 shares@ US$1.678441.4% of flowCommon StockSEC:0000899243-21-044709:0
Canonical exit: 10 Feb 2022 (T+90)
21 of 21 declarations
About Enloe J David Jr
ENLOE J DAVID JR is Chief Executive Officer. He has filed 21 forms in total, and across the sampled recent filings from 2021-11-16 to 2024-04-08, acquisitions total 60297 EUR and sales 0 EUR. The companies mentioned are Societal CDMO, Inc. and Recro Pharma, Inc.